Min Liu

Min Liu

Auto-generated profile, based on publicly available information

Min Liu

Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in Journal of Infection
Verified
Journal Article
Open access
YQYuanyuan Qin
Yuanyuan Qin
YZYihong Zhou
Yihong Zhou
SLSongtao Liu
Songtao Liu
YLYanqiu Lu
Yanqiu Lu
MLMin Liu
Min Liu
YCYaokai Chen
Yaokai Chen
No current academic data is available with respect to the optimal timing to initiate antiretroviral therapy (ART) in HIV-positive patients with talaromycosis. Our study aimed to evaluate the optimal timing of ART initiation for patients presenting with AIDS-related talaromycosis. In this prospective, randomized, open-label multicenter trial, 228 patients from 15 hospitals in China were randomly assigned to an early ART group (initiation of ART within 2 weeks after randomization) and a deferred ART group (initiation of ART 2 weeks after randomization). The primary endpoint was all-cause mortality during the 48 weeks after randomization. We observed a significant difference in mortality between the early ART group and the deferred ART group (2.2% vs. 8.9%, 95%CI: -0.15 to 14.05, p = 0.049). The composite outcome of AIDS-defining events or death in the early ART group was found to be lower than that in the deferred ART group (3.3% vs. 14.9%; 95%CI: 2.93 to 19.23, p = 0.008). The prognosis of HIV-infected patients with talaromycosis in the early ART group was more favorable than that of patients in the deferred ART group. These results demonstrate that early ART initiation should be considered in HIV-infected patients with talaromycosis .

1 January 2017 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
PDF file
XCXiangbo Chi
Xiangbo Chi
MLMin Liu
Min Liu
YCYaokai Chen
Yaokai Chen
Yokenella regensburgeiis a member in the familyEnterobacteriaceaeand a few cases have been reported in immunocompromised hosts. Herein, we described a case of septicemia in a human immunodeficiency virus (HIV) infected patient in South West China, which is the first reported case ofY. regensburgeiinfection in HIV-infected populations. We then reviewed the literature on all the reported cases ofY. regensburgeiinfection worldwide and presented some common features of them. Our case report and literature review will help increase the knowledge of the bacteriumY. regensburgeiand its clinical implications.